Literature DB >> 28396408

Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1.

Keisuke Yanagida1,2,3, Catherine H Liu3, Giuseppe Faraco4, Sylvain Galvani1,2, Helen K Smith3, Nathalie Burg3, Josef Anrather4, Teresa Sanchez3, Costantino Iadecola4, Timothy Hla5,2,3.   

Abstract

The vasculature of the central nervous system (CNS) forms a selective barrier termed the blood-brain barrier (BBB). Disruption of the BBB may contribute to various CNS diseases. Conversely, the intact BBB restricts efficient penetration of CNS-targeted drugs. Here, we report the BBB-regulatory role of endothelial sphingosine 1-phosphate (S1P) receptor-1, a G protein-coupled receptor known to promote the barrier function in peripheral vessels. Endothelial-specific S1pr1 knockout mice (S1pr1iECKO ) showed BBB breach for small-molecular-mass fluorescence tracers (<3 kDa), but not larger tracers (>10 kDa). Chronic BBB leakiness was associated with cognitive impairment, as assessed by the novel object recognition test, but not signs of brain inflammation. Brain microvessels of S1pr1iECKO mice showed altered subcellular distribution of tight junctional proteins. Pharmacological inhibition of S1P1 function led to transient BBB breach. These data suggest that brain endothelial S1P1 maintain the BBB by regulating the proper localization of tight junction proteins and raise the possibility that endothelial S1P1 inhibition may be a strategy for transient BBB opening and delivery of small molecules into the CNS.

Entities:  

Keywords:  blood–brain barrier; drug delivery; endothelium; sphingosine 1–phosphate; tight junction

Mesh:

Substances:

Year:  2017        PMID: 28396408      PMCID: PMC5410849          DOI: 10.1073/pnas.1618659114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  Purification of Mouse Brain Vessels.

Authors:  Anne-Cécile Boulay; Bruno Saubaméa; Xavier Declèves; Martine Cohen-Salmon
Journal:  J Vis Exp       Date:  2015-11-10       Impact factor: 1.355

Review 2.  The dynamic blood-brain barrier.

Authors:  James Keaney; Matthew Campbell
Journal:  FEBS J       Date:  2015-09-08       Impact factor: 5.542

Review 3.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

Authors:  Volker Brinkmann; Andreas Billich; Thomas Baumruker; Peter Heining; Robert Schmouder; Gordon Francis; Shreeram Aradhye; Pascale Burtin
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

Review 4.  The blood-brain barrier: bottleneck in brain drug development.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

5.  Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development.

Authors:  Bongnam Jung; Hideru Obinata; Sylvain Galvani; Karen Mendelson; Bi-sen Ding; Athanasia Skoura; Bernd Kinzel; Volker Brinkmann; Shahin Rafii; Todd Evans; Timothy Hla
Journal:  Dev Cell       Date:  2012-09-11       Impact factor: 12.270

Review 6.  HDL and cholesterol handling in the brain.

Authors:  Cecilia Vitali; Cheryl L Wellington; Laura Calabresi
Journal:  Cardiovasc Res       Date:  2014-06-06       Impact factor: 10.787

7.  Engagement of S1P₁-degradative mechanisms leads to vascular leak in mice.

Authors:  Myat Lin Oo; Sung-Hee Chang; Shobha Thangada; Ming-Tao Wu; Karim Rezaul; Victoria Blaho; Sun-Il Hwang; David K Han; Timothy Hla
Journal:  J Clin Invest       Date:  2011-05-09       Impact factor: 14.808

8.  Object recognition test in mice.

Authors:  Marianne Leger; Anne Quiedeville; Valentine Bouet; Benoît Haelewyn; Michel Boulouard; Pascale Schumann-Bard; Thomas Freret
Journal:  Nat Protoc       Date:  2013-11-21       Impact factor: 13.491

Review 9.  The molecular constituents of the blood-brain barrier.

Authors:  Brian Wai Chow; Chenghua Gu
Journal:  Trends Neurosci       Date:  2015-10       Impact factor: 13.837

10.  Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury.

Authors:  Yejie Shi; Lili Zhang; Hongjian Pu; Leilei Mao; Xiaoming Hu; Xiaoyan Jiang; Na Xu; R Anne Stetler; Feng Zhang; Xiangrong Liu; Rehana K Leak; Richard F Keep; Xunming Ji; Jun Chen
Journal:  Nat Commun       Date:  2016-01-27       Impact factor: 14.919

View more
  68 in total

Review 1.  Cerebral artery myogenic reactivity: The next frontier in developing effective interventions for subarachnoid hemorrhage.

Authors:  Darcy Lidington; Jeffrey T Kroetsch; Steffen-Sebastian Bolz
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-14       Impact factor: 6.200

Review 2.  Strategies for delivering therapeutics across the blood-brain barrier.

Authors:  Georg C Terstappen; Axel H Meyer; Robert D Bell; Wandong Zhang
Journal:  Nat Rev Drug Discov       Date:  2021-03-01       Impact factor: 84.694

3.  Targeting nanoparticles to the brain by exploiting the blood-brain barrier impermeability to selectively label the brain endothelium.

Authors:  Daniel Gonzalez-Carter; Xueying Liu; Theofilus A Tockary; Anjaneyulu Dirisala; Kazuko Toh; Yasutaka Anraku; Kazunori Kataoka
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-23       Impact factor: 11.205

4.  A Combination of G Protein-Coupled Receptor Modulators Protects Photoreceptors from Degeneration.

Authors:  Tivadar Orban; Henri Leinonen; Tamar Getter; Zhiqian Dong; Wenyu Sun; Songqi Gao; Alexander Veenstra; Hossein Heidari-Torkabadi; Timothy S Kern; Philip D Kiser; Krzysztof Palczewski
Journal:  J Pharmacol Exp Ther       Date:  2017-11-21       Impact factor: 4.030

Review 5.  The blood-brain barrier and blood-tumour barrier in brain tumours and metastases.

Authors:  Costas D Arvanitis; Gino B Ferraro; Rakesh K Jain
Journal:  Nat Rev Cancer       Date:  2019-10-10       Impact factor: 60.716

Review 6.  Malaria link of hypertension: a hidden syndicate of angiotensin II, bradykinin and sphingosine 1-phosphate.

Authors:  Gunanidhi Dhangadamajhi; Shailja Singh
Journal:  Hum Cell       Date:  2021-03-08       Impact factor: 4.174

Review 7.  Sphingosine 1-phosphate and inflammation.

Authors:  Hideru Obinata; Timothy Hla
Journal:  Int Immunol       Date:  2019-08-23       Impact factor: 4.823

8.  Sphingosine 1-Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex-Induced Vascular Injury.

Authors:  Nathalie Burg; Steven Swendeman; Stefan Worgall; Timothy Hla; Jane E Salmon
Journal:  Arthritis Rheumatol       Date:  2018-11       Impact factor: 10.995

9.  Metallothionein I as a direct link between therapeutic hematopoietic stem/progenitor cells and cerebral protection in stroke.

Authors:  Helen K Smith; Seiichi Omura; Shantel A Vital; Felix Becker; Elena Y Senchenkova; Gaganpreet Kaur; Ikuo Tsunoda; Shayn M Peirce; Felicity N E Gavins
Journal:  FASEB J       Date:  2017-12-21       Impact factor: 5.191

10.  Sphingosine 1-phosphate-regulated transcriptomes in heterogenous arterial and lymphatic endothelium of the aorta.

Authors:  Eric Engelbrecht; Michel V Levesque; Liqun He; Michael Vanlandewijck; Anja Nitzsche; Hira Niazi; Andrew Kuo; Sasha A Singh; Masanori Aikawa; Kristina Holton; Richard L Proia; Mari Kono; William T Pu; Eric Camerer; Christer Betsholtz; Timothy Hla
Journal:  Elife       Date:  2020-02-24       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.